PR Domain Containing 1, with ZNF Domain (PRDM1) Peptide
-
- Target See all PRDM1 products
- PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PRDM1 antibody (Catalog #: ARP38013_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))
- Background
-
PRDM1 is a protein that acts as a repressor of beta-interferon gene expression. The protein binds specifically to the PRDI (positive regulatory domain I element) of the beta-IFN gene promoter. Transcription of this gene increases upon virus induction. Two alternatively spliced transcript variants that encode different isoforms have been reported.
Alias Symbols: BLIMP1, PRDI-BF1
Protein Interaction Partner: AES,ATXN1,IRF4,TLE1,TLE2,EHMT2,HDAC1,HDAC2,HIST2H3A,KDM1A,PRMT5,PRMT7,SUV39H1,TLE1,TLE2
Protein Size: 789 - Molecular Weight
- 88 kDa
- Gene ID
- 639
- NCBI Accession
- NM_001198, NP_001189
- UniProt
- O75626
-